Log In
Print this Print this

informaSeq Prenatal Test

  Manage Alerts
Collapse Summary General Information
Company Laboratory Corp. of America Holdings
DescriptionNon-invasive prenatal screening for T21, T18 and T13 chromosomal aneuploidies
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsAssess risk for multiple fetal chromosomal aneuploidies in maternal cell-free DNA (cfDNA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today